Why in neurosurgery no need of anaesthesia
awake craniotomy neurosurgery no general anaesthesia reasons
"Awake craniotomy allows for speech, motor, or sensory cortical mapping in real time, hence facilitating a more aggressive resection of the tumor and minimizing risk to function."
- Barash, Cullen, and Stoelting's Clinical Anesthesia, 9e
"Awake craniotomies are performed when tumors or epileptic foci lie close to cortical areas required for either speech or motor function, or to mesial-temporal structures critical to short-term memory."
- Miller's Anesthesia, 10e
| Technique | Description |
|---|---|
| Sedation throughout | Patient lightly sedated the entire time (propofol, dexmedetomidine, or remifentanil infusions) |
| Asleep-Awake-Asleep | General anaesthesia (with supraglottic airway) for opening and closing; airway device removed during the mapping phase so the patient can speak and respond |
How to read pet scan image
how to read interpret PET scan image FDG radiology guide
"FDG competes with glucose for transport into the cell and for enzymatic phosphorylation by hexokinase. Unlike glucose, once phosphorylated to FDG-6-phosphate, it does not undergo further metabolism and is trapped inside the cell."
- Fishman's Pulmonary Diseases and Disorders
| Colour (hot scale) | Meaning |
|---|---|
| Black / dark blue | No or minimal uptake (metabolically inactive) |
| Green / yellow | Moderate uptake |
| Orange / red / white | Very high uptake ("hot spot") |


SUV = Tracer uptake in region (MBq/mL) ÷ [Administered activity (MBq) / Body weight (kg)]
| Metric | What it means |
|---|---|
| SUVmax | Highest uptake in a single pixel (voxel) within the region - reflects the most aggressive part of a tumour |
| SUVmean | Average uptake across the whole region - correlates with overall tumour aggressiveness and survival |

| Step | What to do |
|---|---|
| 1. Look at the CT first | Identify normal anatomy and any structural abnormality |
| 2. Look at PET (MIP) | Maximum Intensity Projection - a whole-body rotating 3D view - scan top to bottom for any hot spots |
| 3. Check normal structures | Confirm expected physiologic uptake is present (brain, heart, liver, kidneys, bladder) |
| 4. Flag abnormal uptake | Any area brighter than surrounding tissue or reference organ (usually liver) |
| 5. Fuse and localise | Use fused images to place abnormal uptake in its exact anatomical location |
| 6. Measure SUV | Read the SUVmax of flagged lesions |
| Structure | Why it's hot |
|---|---|
| Brain (cortex) | High baseline glucose metabolism |
| Heart (myocardium) | Especially in fed state; uses glucose as fuel |
| Liver | Background uptake - used as reference standard |
| Spleen | Moderate uptake |
| Kidneys and ureters | FDG is excreted in urine |
| Urinary bladder | Very hot - FDG accumulates here |
| GI tract (variable) | Bowel wall can show uptake |
| Vocal cords / neck muscles | If patient was talking - can mimic tumour |
| Brown fat (neck/supraclavicular) | In cold conditions, especially young patients |
"Physiologic uptake of FDG is prevalent in the head and neck, especially during contraction of muscles (e.g., neck and thyroarytenoid muscles), and it may therefore be confused with tumor uptake."
- Cummings Otolaryngology Head and Neck Surgery
| Metric | Definition | Use |
|---|---|---|
| MTV (Metabolic Tumour Volume) | Volume of tissue with pathologically elevated FDG in 3D | Reflects total tumour burden |
| TLG (Total Lesion Glycolysis) | SUVmean × MTV | Best overall predictor of prognosis |
| SUVmax | Peak voxel uptake | Most commonly reported |
| Dual time-point imaging | Scan at 1h AND 2h post-injection | Malignant lesions keep rising; benign lesions plateau or drop |
| Tracer | Target | Clinical use |
|---|---|---|
| 18F-DOPA | Dopamine synthesis | Parkinson's disease, gliomas |
| 18F-FET (fluoroethyl-L-tyrosine) | Amino acid transport | Brain tumour recurrence vs radiation necrosis |
| 68Ga-DOTATATE | Somatostatin receptors | Neuroendocrine tumours |
| Amyloid tracers | Beta-amyloid plaques | Alzheimer's disease |
| TAU tracers | TAU protein | Frontotemporal dementia |
| PSMA | Prostate-specific membrane antigen | Prostate cancer staging/recurrence |
I want Ga 68 PSMA image reading full body scan with bony metastasis
Ga-68 PSMA PET CT full body scan bone metastasis prostate cancer reading interpretation
"PSMA PET" "bone metastasis" prostate cancer
PSMA PET bone metastasis reading interpretation distribution axial skeleton
"68Ga-PSMA PET scans have shown promise in identifying nodal and bone metastasis that would have otherwise been missed with conventional CT scans."
- Smith and Tanagho's General Urology, 19e
"This scan is now FDA approved for patients with intermediate- and high-risk prostate cancer and is substantially more sensitive and accurate in the detection of metastases compared to conventional imaging."
- Harrison's Principles of Internal Medicine, 22e
| Structure | Uptake level | Reason |
|---|---|---|
| Salivary glands (parotid, submandibular) | Very high (intense bilateral) | PSMA expressed in normal salivary glands - hallmark of normal scan |
| Lacrimal glands | Moderate-high | PSMA expression in glandular tissue |
| Liver | Moderate | Used as background reference |
| Spleen | Moderate | |
| Kidneys and ureters | High - excreted via kidneys | Renal clearance pathway |
| Urinary bladder | Very high (pooled tracer) | Urinary excretion - can obscure pelvic disease |
| Small bowel | Variable, mild | PSMA expressed in duodenal mucosa |
| Blood vessels (vascular walls) | Mild - related to neovasculature | PSMA on tumour neovasculature |
| Ganglia (celiac, sympathetic chain) | Focal uptake - mimics nodes | Important pitfall |


| Bone Region | Frequency (among patients with bone mets) |
|---|---|
| Pelvis (ilium, sacrum, pubis, ischium) | 70% - most common |
| Ribs, clavicle, sternum | 59% |
| Spine (vertebral bodies) | 57% |
| Skull | Less common |
| Long bones (femur, humerus) | Less common - but important to include in FOV |
PSMA detects bone metastases by targeting the cancer cells directly, not the bone reaction. This is why it detects early lesions that are invisible to conventional bone scan.
| PSA Level | Bone Metastasis Detection Rate |
|---|---|
| < 5 ng/mL | 17.6% |
| 5-10 ng/mL | 34.4% |
| 10-20 ng/mL | 40.8% |
| > 20 ng/mL | 41.4% |
| Parameter | What to assess |
|---|---|
| Location | Exact bone, region (e.g., L3 vertebral body, right iliac wing) |
| SUVmax | Quantify uptake intensity |
| CT correlate | Sclerotic / lytic / no CT change |
| Number of lesions | Oligometastatic (1-3) vs. polymetastatic (4-5) vs. widespread (>5) |
| Cortical breach | Any risk of pathological fracture? |
| Cord involvement | Vertebral mets - is the spinal canal compromised? |
| Disease burden | Definition | Clinical impact |
|---|---|---|
| Solitary lesion | 1 bone met | May be eligible for SBRT / metastasis-directed therapy |
| Oligometastatic | 2-3 lesions | Still potentially curable with aggressive focal therapy |
| Polymetastatic | 4-5 lesions | Systemic therapy preferred |
| Widespread | >5 lesions | Systemic therapy; Lu-177 PSMA theranostics option |
| Modality | Sensitivity | Specificity |
|---|---|---|
| Ga-68 PSMA PET | Higher | Higher |
| Tc-99m bone scan | Lower | Lower (false positives from trauma, arthritis) |
| Pitfall | What it looks like | How to differentiate |
|---|---|---|
| Sympathetic ganglia (celiac, stellate) | Focal uptake mimicking a node or met | Typical location, no CT lesion, bilateral symmetric |
| Paget's disease | Very high bone uptake | CT shows classic expanded coarsened trabeculae |
| Fracture / healing bone | Mild uptake | CT shows fracture line; no aggressive bone destruction |
| Haemangioma | Vertebral focal uptake | CT shows classic striated "corduroy" pattern |
| Ureter/urine contamination | Linear activity in pelvis | Follow on sequential images; activity moves |
| Bladder masking pelvic nodes/prostate bed | Bladder obscures uptake nearby | Late imaging or furosemide flush to empty bladder |
"A targeted radio-ligand therapy, 177Lu-PSMA-617, targets prostate-specific membrane antigen, which is highly expressed in prostate cancer, as demonstrated by a positive prostate-specific membrane antigen PET."
- Goldman-Cecil Medicine
In t12 metastasis seen 18
Ga-68 PSMA PET SUVmax 18 T12 bone metastasis prostate cancer clinical significance management
| SUVmax Range on PSMA PET | Interpretation |
|---|---|
| < 3-4 | Likely benign / background level |
| 4 - 8 | Low-moderate PSMA avidity - equivocal, needs CT correlation |
| 8 - 15 | High PSMA avidity - strongly suspicious for metastasis |
| > 15 (your finding: 18) | Intensely PSMA-avid - confirmed malignant, highly aggressive |
PSMA is expressed 100-1000 fold higher in prostate cancer cells vs. normal tissue, giving very high lesion-to-background ratios. An SUVmax of 18 far exceeds physiologic background at any spinal level.
"The thoracic spinal column is most commonly involved... Prostate and ovarian cancers occur disproportionately in the sacral and lumbar vertebrae, probably from spread through Batson's plexus, a network of veins along the anterior epidural space."
- Harrison's Principles of Internal Medicine, 22e
| CT finding at T12 | What it means |
|---|---|
| Sclerotic (dense/white) lesion | Blastic met - classic for prostate cancer; bone reacting to tumour |
| Lytic (dark/destructive) lesion | Less common in prostate; risk of collapse/fracture |
| Mixed sclerotic-lytic | Aggressive or treated lesion |
| No CT change | Early micrometastasis - PSMA detected it before bone reacts |
| Cortical breach / pedicle destruction | High fracture risk - urgent surgical/ortho-oncology review |
| Posterior element involvement | Risk of epidural extension and cord compression |
| Reduced vertebral height | Pathological compression fracture - urgent intervention |
"Pain is usually the initial symptom of spinal metastasis; it may be aching and localized or sharp and radiating... A recent onset of persistent back pain, particularly if in the thoracic spine (which is uncommonly involved by spondylosis), should prompt consideration of vertebral metastasis."
- Harrison's Principles of Internal Medicine, 22e
"Up to 40% of patients who present with cord compression at one level are found to have asymptomatic epidural metastases elsewhere - imaging of the entire length of the spine is important."
- Harrison's Principles of Internal Medicine, 22e

| Option | Details |
|---|---|
| Stereotactic Body Radiotherapy (SBRT) | High-dose focused radiation to T12 in 1-5 fractions. Preferred for oligometastatic disease and radioresistant histology. Can sterilise the lesion. |
| Metastasis-directed therapy (MDT) | SBRT + continuation/intensification of systemic therapy |
| Surgery | If structural instability, cord compression, or radioresistance |
"Stereotactic body radiotherapy, which delivers high doses of focused radiation, is preferred for radioresistant tumor types and for patients requiring re-irradiation."
- Harrison's Principles of Internal Medicine, 22e
| Option | Details |
|---|---|
| Systemic therapy | ADT + abiraterone, enzalutamide, or docetaxel depending on castration status |
| 177Lu-PSMA-617 (Lutetium) | If PSMA-avid disease confirmed (SUVmax 18 qualifies strongly) - targeted radionuclide therapy |
| Palliative RT to T12 | If symptomatic - 8 Gy single fraction or 20 Gy/5 fractions for pain control |
| Zoledronic acid / Denosumab | Bone-protective agents to reduce skeletal-related events |
"Motor deficits (paraplegia or quadriplegia), once established for >12 h, do not usually improve, and beyond 48 h, the prognosis for substantial motor recovery is poor."
- Harrison's Principles of Internal Medicine, 22e
| Parameter | Your Findings | Clinical Significance |
|---|---|---|
| Tracer | Ga-68 PSMA | Directly targets prostate cancer cells |
| Location | T12 vertebra | Thoracolumbar junction - high-risk site |
| SUVmax | 18 | Intensely avid - unambiguous metastasis |
| Disease stage | M1b (bone metastasis) | Metastatic prostate cancer |
| Immediate next step | MRI whole spine | Assess cord compression, structural integrity |
| Urgent clinical check | Neurology exam | Rule out impending cord compression |
| Lu-177 eligibility | Yes (PSMA-avid confirmed) | Theranostic candidate if polymetastatic |
Which suture is good for injury over anterior leg by sharp object
best suture material anterior leg pretibial laceration sharp injury wound closure
suture material selection anterior leg laceration monofilament nylon size
| Property | Detail |
|---|---|
| Type | Non-absorbable, monofilament, synthetic |
| Size | 3-0 (thick/gaping wound) or 4-0 (standard laceration) |
| Tissue reaction | Very low - synthetic monofilament causes minimal inflammation |
| Tensile strength | High - retains up to 2/3 of strength even after 11 years in tissue |
| Infection risk | Low - single strand = no interstices for bacteria to harbour |
| Handling | Stiff, needs extra throws on knot (3-4 throws minimum) |
| Removal | Required at 10-14 days for lower leg (longer than face) |
"Nylon: General surgical use - skin closure, abdominal wall mass closure, hernia repair, plastic surgery, neurosurgery, microsurgery, ophthalmic surgery. Contraindications: None."
- Bailey and Love's Short Practice of Surgery, 28e
| Suture | Why to Avoid |
|---|---|
| Silk | High tissue reaction, promotes infection, moderate reactivity - unsuitable for routine skin closure. "Risk of infection and tissue reaction makes silk unsuitable for routine skin closure" - Bailey and Love |
| Braided polyester (Mersilene/Ethibond) | Multi-filament = bacterial wicking risk in a poorly vascularised area |
| Catgut / Chromic catgut | Unpredictable absorption, high tissue reaction, loses strength within 7-21 days - too early for a slow-healing pretibial wound |
| Vicryl (polyglactin) for skin | Absorbable - adequate strength only 2-3 weeks; anterior leg needs support for longer. Can cause suture abscess if used percutaneously |
| Staples | Avoid over thin pretibial skin - high risk of tearing; poor cosmesis |
| Wound | Size (USP) | Metric equivalent |
|---|---|---|
| Deep layer (if any subcutaneous tissue present) | 3-0 Vicryl (absorbable - buried) | Metric 2 |
| Skin closure - standard laceration | 3-0 or 4-0 Nylon | Metric 2 / 1.5 |
| Skin - thin elderly skin, delicate closure | 4-0 Nylon | Metric 1.5 |
| Very fine skin edges | 5-0 Nylon | Metric 1 |
"The distance of insertion from the edge of the wound should correspond to the thickness of the tissue being sutured. Each successive suture should be placed at twice this distance apart."
- Bailey and Love's Short Practice of Surgery, 28e
"Mattress sutures... are very useful in producing an accurate approximation of wound edges, especially when the edges to be anastomosed are irregular in depth or disposition."
- Bailey and Love's Short Practice of Surgery, 28e
| Decision | Answer |
|---|---|
| Best suture material | 3-0 or 4-0 Monofilament Nylon (Ethilon) |
| Alternative | 3-0 or 4-0 Polypropylene (Prolene) |
| Deep layer | 3-0 Vicryl (buried, absorbable) |
| Technique | Simple interrupted OR vertical mattress |
| Needle type | Cutting or reverse-cutting (for skin) |
| Suture removal | 12-14 days (longer than most body sites) |
| Avoid | Silk, catgut, braided materials, staples on thin pretibial skin |
Read this report and tell me the interpretation and how to treat and advise
AEC 1388 IgE >1000 eosinophilia high IgE causes investigation treatment young male
absolute eosinophil count 1388 IgE >1000 young adult workup treatment India parasitic
| Test | Result | Normal | Severity |
|---|---|---|---|
| Absolute Eosinophil Count (AEC) | 1388 /cmm | 20-500 /cmm | 🔴 HIGH - nearly 3x upper limit |
| Total IgE (Immunoglobulin E) | >1000 IU/mL | ≤100 IU/mL | 🔴 MARKEDLY HIGH - 10x upper limit |
| AEC Level | Grade |
|---|---|
| 500-1500 /cmm | Mild eosinophilia |
| 1500-5000 /cmm | Moderate eosinophilia |
| >5000 /cmm | Severe (Hypereosinophilic syndrome) |
"Eosinophilia is present if blood eosinophils exceed ~0.35-0.5 × 10⁹/L. Reactive eosinophilia is typically associated with allergic processes and parasitic infections."
- Henry's Clinical Diagnosis and Management by Laboratory Methods
"Moderate to severe peripheral eosinophilia is most commonly associated with infection by helminths, including nematodes, trematodes, and cestodes."
- Henry's Clinical Diagnosis and Management by Laboratory Methods
"Key causes of eosinophilia: Parasitic - trichinosis, filariasis, schistosomiasis; Allergic - urticaria, hay fever, asthma"
- Henry's Clinical Diagnosis (Box 34.4)
| Parasite | Why to consider | Clue |
|---|---|---|
| Roundworm (Ascaris lumbricoides) | Most common in India | Abdominal pain, vomiting |
| Hookworm (Ancylostoma/Necator) | Very common, rural India | Anaemia, soil contact |
| Toxocara canis/cati (Visceral Larva Migrans) | Dog/cat contact | Hepatomegaly, wheeze |
| Filariasis (Wuchereria bancrofti) | Endemic India - Gujarat | Limb swelling, nocturnal fever |
| Strongyloides stercoralis | Highest IgE elevation of all GI parasites | Diarrhoea, urticarial rash |
| Trichinella spiralis | Less common | Muscle pain, periorbital oedema |
| Investigation | What it detects |
|---|---|
| Stool for ova and cyst / parasites × 3 samples | Direct detection of GI helminths |
| Peripheral blood smear | Rule out filarial microfilariae; assess eosinophil morphology |
| CBC with differential | Full blood picture - rule out hypereosinophilic syndrome |
| Chest X-ray | Loeffler syndrome (migratory pulmonary infiltrates in larval migration) |
| Urine routine | Baseline; filariasis may cause chyluria |
| Investigation | What it detects |
|---|---|
| Serology: Toxocara ELISA | If abdominal pain/hepatomegaly/wheeze |
| Filarial antigen card test / nocturnal blood smear | If from filaria-endemic area (Gujarat can have cases) |
| Skin prick test / specific IgE (RAST) | If allergic cause suspected |
| Ultrasound abdomen | Liver/spleen for granulomas, eosinophilic infiltration |
| Spirometry | If asthma suspected |
| ANA, ANCA, ESR | If autoimmune/Churg-Strauss suspected |
| Drug | Dose | Purpose |
|---|---|---|
| Cetirizine / Levocetirizine | 10 mg / 5 mg OD at night | Antihistamine for allergic symptoms |
| Montelukast | 10 mg OD | Anti-leukotriene - especially if asthma component |
| Inhaled corticosteroid | If asthma confirmed on spirometry | Long-term controller |
| Symptom | Possible Reason |
|---|---|
| Swelling of limbs especially legs | Filariasis (lymphoedema) |
| Cough + difficulty breathing | Loeffler syndrome (larval migration) |
| Chest pain / palpitations | Eosinophilic myocarditis (if AEC rises) |
| Severe abdominal pain | Intestinal obstruction from worm load |
| Jaundice | Biliary ascariasis |
| Skin rash / urticaria | Allergic/larval migration |
| Point | Detail |
|---|---|
| Diagnosis | Likely parasitic eosinophilia (helminthic) with/without atopy |
| AEC severity | Mild-moderate (1388 /cmm) |
| IgE severity | Markedly elevated (>1000 - 10x normal) |
| Most urgent exclusion | Rule out hypereosinophilic syndrome if AEC >1500 or organ symptoms |
| First treatment | Albendazole 400 mg stat + repeat CBC in 4-6 weeks |
| Referral needed | Only if no improvement or AEC continues to rise |